Kaufmann in 1960 first recognised that patients with dystrophia myotonica had an unexpectedly high perioperative morbidity and mortality, caused primarily by cardiorespiratory complications) Patients with the disease frequently present for removal of cataracts, correction of anterior open bite and cholecystectomy.
Subsequently, hypoventilation and ineffectual coughing may lead to the development of a chest infection.
In this case report we describe the use of intravenous infusions of propofol and atracurium in a patient undergoing bilateral eminectomy to correct recurrent dislocation of the mandible.
Case report
A 41-year-old woman, weighing 64 kg, presented for correction of recurrent dislocation of the mandible. Dystrophia myotonica had been diagnosed 11 years previously. She had received several general anaesthetics in the past and was unaware of any problems.
On systematic enquiry she gave a history of increasing muscle weakness and was unable to walk more than 100 metres. Physical examination showed features of dystrophia myotonica. No active cardiovascular or respiratory pathology was demonstrated.
Haematological and biochemical investigations, including thyroid and arterial blood gas studies, were normal, as was her chest x-ray. A spirograph recorded a FVC of 2500 ml and a FEVt of 2300 ml. The only ECG abnormality was an inverted T wave in lead V2.
The patient was given ranitidine 50 mg IM two hours preoperatively, midazolam 5 mg IM one-half hour before surgery, and mist. sodium citrate 30 mljust before leaving the ward. On arrival in the operating theatre she was calm and had no respiratory difficulties. Following monitoring and pre-oxygenation for five minutes, anaesthesia was induced with glycopyrrolate 0.3 mg, propofol 125 mg and atracurium 30 mg. Intubation was performed with a 7 mm preformed cuffed nasal endotracheal tube. The patient was placed on a heated mattress and oesophageal temperature recorded.
Anaesthesia was maintained with nalbuphine 3 mg IV and an infusion of propofol 0.3 mg" kg -I. min -I for 20 minutes then reduced to 0.15 rag. kg -1 .min -I for the remainder of the procedure. Muscle relaxation was obtained by a separate infusion of atracurium 0.3-0.6mg.kg-l.hr -t. Both drags were administered by syringe pumps.
Dexamethasone 8 mg and benzylpenicillin 600 mg were given IV prior to incision. Neuromuscular function was CAN I ANAESTH 1989 / 36:2 / pp200-3 assessed every 20 seconds using the integrated electromyographic response to a "train-of-four" stimulus (Datex Relaxograph). The atracurium infusion was adjusted to maintain the train-of-four response such that the first twitch (Tt) response was ten per cent of the control twitch (To) response.
The propofol infusion was adjusted to maintain anaesthesia as judged clinically and to keep the systolic BP in the range 100-90 mmHg with the aid of 15 degree head up tilt. Further doses of nalbuphine 2 mg were given at 1 and 2~/2 hours after the start of surgery.
The infusion rate of atracurium was reduced to 0.2 rag' kg-t' hr -I 40 minutes before, and discontinued 20 minutes before the end of surgery. Neuromuscular transmission was back to preoperative levels on completion of the procedure. At this time a further 8 mg dexamethasone and 600 mg benzylpenieillin were given, and the propofol infusion and nitrous oxide were discontinued.
Total duration of surgery was four hours ten minutes. The patient regained conciousness ten minutes later, and was extubated awake in the left lateral position after assessment of her tidal volume, with a Wrights respirometer.
Postoperative muscle power, ability to cough and blood gases were normal and recovery was uneventful. There was no nausea or vomiting and only a single dose of nalbuphine was needed for pain relief.
Discussion
Dystrophia myotonica, also known as myotonia atrophica, Hofmann's disease or Curschmann-Steinerts disease, is the most common form of myotonia 3 and affects approximately 5:100,000 of the population, more frequently males. 7 It is the most severe of a group of hereditary muscle diseases, collectively called the myotonic syndrome, charaeterised by myotonia, weakness and atrophy of certain groups of muscles; the three best described being dystrophia myotonica, myotonica congenita and paramyotonica eongenita. The clinical features of the disease have been well reviewed by Prnzanski, s and more recently by Aldridge. 7 Patients with dystrophia myotonica pose major anaesthetic management problems for not only is it a true multi-system disease, 2 but there is an abnormal response to many anaesthetic drugs and there are frequently postoperative cardio-respiratory complications.
Most perioperative and early complications are drug related, whereas later complications tend to reflect the severity of the disease. The response of myotonic patients to anaesthetic drugs is summarized below.
Induction agents THIOPENTONE Dundee, 9 and also Bourke and Zuck, m reported several patients who suffered both prolonged apnoea and respiratory depression even after small doses of thiopentone. These effects may be enhanced by opiate premedication.
The mechanism of this sensitivity is unclear. It was originally thought to be a curare-like effect. A more likely explanation is that thiopentone does not act directly on abnormally sensitive muscle, but that muscle wasting and weakness depresses ventilation which is accentuated by this drug.
ETOMIDA/E This has been used sucessfully for patients undergoing correction of maxillo-facial deformitiest 1 but its use as an infusion is now contraindicated because of the adrenal suppression associated with its use.12 METHOHEXITONE Although recovery from a single bolus is rapid, there is a marked delay in recovery when used as an infusion over long duration.
Muscle relaxants
SLICCINYLCHOLINE produces an abnormal and unpredictable response, which closely follows the biphasic increase in serum potassium seen in myotonic patients. Initially the severity of myotonia is decreased then markedly increased at higher potassium concentrations, producing spontaneous spasms and rigidity, 16 thus making intubation very difficult.
Peterson et al. used electromyographic studies to show a persistent state of contraction after the drug,t4 and in a patient with myotonia congenita Paterson noted that relaxation did not occur until 3-31/2 minutes after a dose of 50-75 mg. Is Thiel concluded that depolarizing neuromuscular blocking drugs are best avoided, s COMPETITIVE MUSCLE RELAXANTS are not contraindicated, but some patients with dystrophia myotonica show increased sensitivity to competitive neuromuscular blocking drugs.
However, the problem is that myotonia can be precipitated on reversal of these drugs with anticholinesterases. Kennedy and Wolf (1937) reported an increase in myotonia following intravenous neostigmine,16 making its use for reversal of neuromuscular block both unpredictable and hazardous.
Atracurium is rapidly degraded by "Hofmann elimina-tion" leading to predictable recovery and has been used as a continuous infusion in myotonic patients. It appears to be safe, reliable and does not require reversal with anticholinesterases, t 7 DANTROLENE has been used for sole relaxation during surgery but proved insufficient, is
Inhalational agents
These may produce shivering which can precipitate myotonia in the early postoperative period. Although most frequently associated with halothanc, shivering may occur after enflurane or isoflurane.
INTRAVENOUS REGIONAL ANAESTHESIA is probably the method of choice for anaesthesia of the extremities since the direct effect of local anaesthetic agents on muscle membrane may protect against myotonia. These factors influenced our choice of drugs for the anaesthetic management of this patient. We wished to avoid the use of inhalational agents because of the risk of postoperative shivering and decided that an intravenous technique would be more appropriate.
Propofol appeared to be a suitable agent for induction and maintenance of anaesthesia by intravenous infusion because of its minimal cummulative effects and rapid offset of action when the infusion is stopped. However, there are few reports of its use in procedures lasting more than one hour and no reports of its use in dystrophia myotonica.
Atracurium was chosen for neuromuscular relaxation because of its cardiovascular stability, lack of accumulation and rapid elimination profile, so obviating the need for anticholinesterases. Its use has been reported previously in patients with dystrophia myotonica, but as intermittent boluses rather than infusions.
Naibuphine, a new semi-synthetic narcotic agonistantagonist analgesic of the phenanthrene series, has been recommended for the relief of moderate to severe pain. Given parenterally it is 0.8-0.9 times as effective as morphine. 19 It is claimed that the dose-related respiratory depression associated with other opioids does not occur with nalbuphine. ~~
Conclusion
There were no intraoperative problems associated with this technique, the patient was haemodynamically stable throughout and surgical conditions were excellent. Emergence from anaesthesia was rapid and there were no postoperative problems.
We feel this technique offers a safe alternative to CANADIAN JOURNAL OF ANAESTHESIA inhalational anaesthesia for patients with dystrophia myotonica.
